Financial Performance - Revenues for the three months ended June 30, 2022, totaled $244.6 million, a decrease of approximately $12.8 million compared to the same period in 2021[202]. - Expenses for the three months ended June 30, 2022, totaled $174.2 million, a decrease of approximately $0.9 million compared to the same period in 2021[202]. - Rental income for the six months ended June 30, 2022, was $428.3 million, a decrease of $30.4 million compared to the same period in 2021, primarily due to the impact of cash basis operators[206]. - Mortgage interest income for the six months ended June 30, 2022, was $40.1 million, a decrease of $7.5 million compared to the same period in 2021[206]. - Total other income for the six months ended June 30, 2022, was $133.9 million, an increase of approximately $58.8 million compared to the same period in 2021, mainly due to gains on asset sales[208]. - Nareit FFO for the three months ended June 30, 2022, was $160.6 million, compared to $180.8 million for the same period in 2021[212]. - General and administrative expenses for the six months ended June 30, 2022, were $35.2 million, an increase of $3.8 million compared to the same period in 2021[209]. - Acquisition, merger, and transition-related costs for the six months ended June 30, 2022, were $5.5 million, an increase of $3.7 million compared to the same period in 2021[209]. COVID-19 Impact - Omega Healthcare Investors, Inc. has reported that many operators have failed to make contractual payments under lease and loan agreements due to reduced revenue and increased expenses from the COVID-19 pandemic[158]. - Average occupancy levels in facilities have improved since early 2021 but have not returned to pre-pandemic levels, with ongoing staffing shortages impacting admissions[163]. - Federal relief efforts for healthcare providers were limited in 2021, and further government support is needed to offset the impacts of COVID-19 on operators[164]. - The company remains cautious about the long-term impact of COVID-19 on operators, particularly regarding staffing and occupancy recovery[167]. - The ongoing uncertainties related to COVID-19, including the impact of vaccination programs and potential new variants, continue to pose risks to the business[166]. - The ongoing impacts of COVID-19 have restricted operators from pursuing certain therapy efficiencies under PDPM, potentially affecting their financial performance[186]. Government Support and Regulations - The CARES Act authorized approximately $178 billion to be distributed through the Provider Relief Fund, with $9.5 billion specifically allocated for skilled nursing facilities (SNFs) and $2.5 billion tied to performance-based incentive payments[178]. - The American Rescue Plan Act increased the Federal Medical Assistance Percentage (FMAP) by 10 percentage points for state home and community-based services expenditures from April 1, 2021, to March 30, 2022[183]. - The Medicare sequester percentage is scheduled to return to 2% as of July 1, 2022, and will be extended through fiscal year 2031, impacting reimbursement rates for healthcare providers[180]. - Approximately $100 million in additional FMAP funds for nursing homes was approved by the State of Florida in November 2021, with a 7.8% increase in Medicaid reimbursement rates effective March 2022[183]. - The Centers for Medicare and Medicaid Services (CMS) has implemented quality of care initiatives, including staff vaccination requirements for over 15,000 Medicare and Medicaid-participating nursing homes[181]. - Regulatory changes in the healthcare industry could materially impact operators' financial conditions, affecting their ability to meet obligations to Omega[169]. - The healthcare industry is heavily regulated, and changes in laws and regulations can significantly affect the operations and financial conditions of operators[171]. Company Operations and Strategy - The company anticipates that the operating results of additional operators may be materially affected if government relief is insufficient, potentially leading to defaults on contractual obligations[164]. - Increased labor costs and shortages are expected to continue affecting operators, alongside heightened competition for facility acquisitions in the U.S.[168]. - The company is continuously evaluating its portfolio and may opportunistically sell assets or portfolios of assets as part of operator restructuring transactions[168]. - The company recorded impairments on six facilities totaling approximately $11.2 million during the same period, with $3.5 million related to facilities classified as held for sale[192]. - The company repurchased 5.2 million shares at an average price of $27.32 per share during the six months ended June 30, 2022, as part of a $500 million stock repurchase program[193]. - The company anticipates that its primary sources of cash will be adequate to fund cash flow needs through the next twelve months[213]. Cash Flow and Assets - Cash, cash equivalents, and restricted cash totaled $168.5 million as of June 30, 2022, an increase of $144.1 million compared to December 31, 2021[226]. - Operating activities generated $305.2 million of net cash flow for the six months ended June 30, 2022, a decrease of $73.1 million compared to the same period in 2021[227]. - Net cash flow from investing activities was an inflow of $277.2 million for the six months ended June 30, 2022, compared to an outflow of $387.1 million for the same period in 2021[228]. - Net cash flow from financing activities was an outflow of $436.8 million for the six months ended June 30, 2022, compared to an outflow of $54.3 million for the same period in 2021[229]. - As of June 30, 2022, total assets were $9.5 billion, total equity was $3.9 billion, and total debt was $5.4 billion, with debt representing approximately 57.7% of total capitalization[214]. - The weighted-average annual interest rate of the company's debt was 4.1%, with 98% of the debt having fixed interest payments as of June 30, 2022[215]. - As of June 30, 2022, the company had $214.5 million of commitments to fund construction and capital improvements[224].
Omega Healthcare Investors(OHI) - 2022 Q2 - Quarterly Report